RecruitingNot ApplicableNCT06872567
Randomized Controlled Study Evaluating Genicular Artery Embolization Against Intra-Articular Corticosteroid Knee Injection for Osteoarthritic Knee Pain
Resorbable Embolization MicroSpheres for OsteoaRthritis Benefit
Sponsor
North American Science Associates Ltd.
Enrollment
126 participants
Start Date
Oct 1, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
Multi-center, prospective, randomized trial of GAE using Nexsphere-F against steroid injection
Eligibility
Min Age: 40 Years
Inclusion Criteria2
- Patient has localized knee pain
- Must be an appropriate candidate for arterial vascular access procedure
Exclusion Criteria2
- Known sensitivity or allergy to implant materials
- Unable or unwilling to comply with study requirements
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEgenicular artery embolization
genicular artery embolization
DRUGCorticosteroid Injection
Corticosteroid Injection
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06872567
Related Trials
Effects of Core Stabilization Exercises in Female Patients With Gonarthrosis
NCT074823321 location
Recombinant Human Growth Hormone (rHGH) for Knee Osteoarthritis (KORR)
NCT070360031 location
Advanced Brain Imaging-TKA (fMRI-TKA)
NCT074640801 location
Analysis of the Loss of Muscle Force, Power and Motor Control to Predict the Risk of Falls in Patients With Knee OA
NCT066116181 location
An Implementation Science Approach to Evaluating Self-Administered Acupressure for Knee Osteoarthritis in Older-Aged Adults in the Community
NCT073290231 location